Skip to main content
. 2022 Apr 15;27:32. doi: 10.4103/jrms.jrms_641_21

Table 2.

Clinical features of COVID-19 patients with gastrointestinal symptoms

Variable All patients, n (%) Severe patients (n=512), n (%) Nonsevere patients (n=601), n (%) P OR (95% CI)
Nausea 387 (34.7) 183 (35.7) 204 (33.9) 0.530
Diarrhea 286 (25.7) 111 (21.7) 175 (29.1) 0.005 0.67 (0.51-0.88)
Vomiting 260 (23.4) 133 (25.9) 127 (21.1) 0.057
Abdominal pain 168 (15.0) 59 (11.5) 109 (18.1) 0.002 0.58 (0.41-0.82)
Nausea and vomiting 202 (18.1) 101 (20.7) 61 (15.9) 040.1 1.37 (1.01-1.86)
Diarrhea and vomiting 69 (8.4) 38 (7.4) 61 (9.3) 0.260
Diarrhea and abdominal pain (lower GI) 86 (7.9) 20 (5.2) 12 (10.3) 04000 0.48 (0.30-0.77)
Nausea and vomiting and Diarrhea 9 (6.6) 39 (6.6) 90 (6.6) 0.662
Nausea and vomiting and Abdominal pain (upper GI) 62 (4.6) 28 (5.4) 29 (3.9) 0.296
Nausea and vomiting and diarrhea and abdominal pain (gastroenteritis) 26 (2.6) 19 (2.7) 16 (2.4) 0.803

GI=Gastrointestinal; OR=Odds ratio; CI=Confidence interval